Nuveen Asset Management, LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 112 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$15,700,000
-3.7%
656,928
-41.2%
0.01%
-16.7%
Q4 2020$16,304,000
-4.6%
1,116,723
-7.2%
0.01%
-14.3%
Q3 2020$17,093,000
+63.0%
1,203,787
+68.9%
0.01%
+75.0%
Q2 2020$10,484,000
+313.9%
712,739
+15.9%
0.00%
+300.0%
Q1 2020$2,533,000
-13.1%
614,853
+1.5%
0.00%0.0%
Q4 2019$2,914,0000.0%605,672
+26.0%
0.00%0.0%
Q3 2019$2,914,000
+7.9%
480,772
+15.5%
0.00%0.0%
Q2 2019$2,700,000416,1360.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders